For those who prefer to use their drug plan, the question is whether it's economically driven or whether it's a matter of feeling more confident getting a professional opinion. I think it's important to separate those two scenarios. You don't want to discourage people who need that reassurance of a doctor that they're making the right diagnosis and that the product they're contemplating is the right product to treat that ailment.
At the same time, if that isn't the issue, if what we're looking at is an economically driven decision, and it has nothing to do with whether or not they feel this is the right medicine for them, then I think there's something inherently bothersome there, because resources that might be used for more complex cases are being taken up. Time is being taken away from care by front-line physicians when that matter could be taken care of by the patient themselves. It's not about taking away options; it's about lowering barriers. Giving options to those people who can effectively self-treat frees up resources elsewhere in the system for people for whom doing so is more of a challenge.